Rei Ishihara1, Yuki Murakami1, Saki Watanabe1, Tsukasa Oda2, Masanobu Sunaga1, Eiko Yamane1, Nobuhiko Kobayashi3, Yohei Osaki4, Takuma Ishizaki3, Hiroaki Shimizu3, Hiromi Koiso3, Hirono Iriuchishima3,5, Nanami Gotoh1, Tetsuhiro Kasamatsu1, Akihiko Yokohama5, Takayuki Saitoh1, Hirokazu Murakami1, Norifumi Tsukamoto4, Hiroshi Handa3 (1.Graduate School of Health Sciences, Gunma University, Gunma, Japan, 2.Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan, 3.Department of Hematology, Gunma University, Gunma, Japan, 4.Oncology Center, Gunma University Hospital, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan)
Session information
Oral Session
Oral Session 3-9B MM: BM microenvironment
Sun. Oct 14, 2018 9:40 AM - 10:40 AM No.9 (Osaka International Convention Center, 10F 1008)
Chair: Junya Kuroda (Division of Hematology and Oncology, Kyoto Prefecilnal University of Medicine, Japan)
【E】
Jumpei Teramachi1,2, Hirofumi Tenshin1,3, Masahiro Hiasa1,3, Asuka Oda1, Bat-Erdene Ariunzaya1, Takeshi Harada1, Masami Iwasa1, Shiro Fujii1, Kimiko Sogabe1, Shingen Nakamura1, Hirokazu Miki4, Masahiro Oura1, Kumiko Kagawa1, Itsuro Endo1,5, Toshio Matsumoto6 (1.Department of Hematology, Endocrinology and Metabolism, Tokushima University , Japan, 2.Tissue Regeneration, Tokushima University, Japan, 3.Orthodontics and Dentofacial Orthopedics, Tokushima University, Tokushima, Japan, 4.Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan, 5.Chronomedicine, Tokushima University, Tokushima, Japan, 6.Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan)
Hirofumi Tenshin1,2, Jumpei Teramachi2,3, Masahiro Hiasa1,2, Kotaro Tanimoto1,2, Mohannad Ashtar1,2, Bat Erdene Ariunzaya2, Masami Iwasa2, Takeshi Harada2, Shingen Nakamura2, Hirokazu Miki4, Kimiko Sogabe2, Masahiro Oura2, Shiro Fujii2, Kumiko Kagawa2, Itsuro Endo2, Eiji Tanaka1, Toshio Matsumoto5, Masahiro Abe2 (1.Department of Orthodontics and Dentofacial Orthopedics,Tokushima University, Japan, 2.Department of Hematology, Endocrinology and Metabolism, Tokushima University, 3.Department of Tissue Regeneration, Tokushima University, 4.Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, 5.Fujii Memorial Institute of Medical Sciences, Tokushima University)
Kentaro Serizawa, Hirokazu Tanaka, Ayano Fukui, Ryosuke Fujiwara, Keigo Sano, Takahiro Kumode, Yasuhiro Taniguchi, Yasuyoshi Morita, Espinoza Luis, Yoichi Tatsumi, Takashi Ashida, Itaru Matsumura (Kindai University Faculty of Medicine, Osaka, Japan)
Takayuki Tabayashi, Yuka Tanaka, Yasuyuki Takahashi, Yuta Kimura, Tatsuki Tomikawa, Junichi Watanabe, Tomoe Anan, Morihiko Sagawa, Reiko Nakaseko, Michihide Tokuhira, Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan)
Mikio Okayama1,2, Shotaro Kitabatake1, Mariko Sato1, Kota Fujimori1, Koichi Samata1, Daiju Ichikawa1, Maiko Matsushita1, Yutaka Suto3, Genji Iwasaki3, Taketo Yamada4, Fumiyuki Kiuchi5, Shinichiro Okamoto2, Yutaka Hattori1 (1.Clin. Physiol.and Therapeutics, Keio Univ. Faculty of Pharmacy, Tokyo, Japan, 2.Division of Hematol., Keio University School of Med., Tokyo, Japan, 3.Takasaki Health and Welfare University, Faculty of Pharmacy, Takasaki, Japan, 4.Department of Pathology, Saitama Medical University, Saitama, Japan, 5.Nature Medicines, Keio Univ. Faculty of Pharmacy, Tokyo, Japan)